Source: Pharmacy Times articles
The recommendation comes after positive phase 3 trial results in adult patients with relapsed and refractory multiple myeloma.
Read More
by | Feb 26, 2024 | Myeloma News | 0 comments
Source: Pharmacy Times articles
The recommendation comes after positive phase 3 trial results in adult patients with relapsed and refractory multiple myeloma.
Read More